@article{TP13853,
author = {Andrea Garatti and Alessandro Giamberti and Alessandro Frigiola and Lorenzo Menicanti},
title = {The ideal substitute for tricuspid valve replacement in patients with congenital heart disease: an unsolved dilemma},
journal = {Translational Pediatrics},
volume = {6},
number = {2},
year = {2017},
keywords = {},
abstract = {In a recent paper, Burri and colleagues (1) addressed the complex theme of bioprosthesis durability in patients with congenital heart disease (CHD) operated of tricuspid valve replacement (TVR). The authors reviewed a consecutive series of 51 patients (mean age 32 years) affected by CHD (mainly Ebstein disease) operated over a 25 years period of TVR with a bioprosthesis.},
issn = {2224-4344}, url = {https://tp.amegroups.org/article/view/13853}
}